2016 The Year of Pharmacy Enforcement

Conclusion The unfortunate thing is that in all four cases this was preventable.  In the Palisades, Nashville and CVI cases, the proper internal review and the establishment of SOPs, basic training, and monitoring were the need. In the case of MedIV, establishing a Quality Management System and following current Good Manufacturing Practices could have prevented needless tragedy. Over the years, pharmacy compliance programs have been sorely neglected. Pharmacies and pharmacists need to take compliance seriously and take the necessary steps to establish or reinforce their programs -- before the Government comes calling, which seems more likely with each passing day. by Dr. Seth Whitelaw, President & CEO of Whitelaw Compliance Group, LLC. and Editor, Life Science Compliance Update       Related StoriesStates Target Compounding Pharmacies over Claims to Military Health ProgramDOJ Becoming Comfortable With Permitting Truthful, Non-misleading PromotionPharmacy Benefit Managers Begin to Cut Ties With Specialty Pharmacies 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs